ClinicalTrials.Veeva

Menu

Carnosine Supplementation and Cardiovascular Function

J

Josip Juraj Strossmayer University of Osijek

Status

Enrolling

Conditions

Carnosine

Treatments

Dietary Supplement: Carnosine supplementation
Dietary Supplement: Controls

Study type

Interventional

Funder types

Other

Identifiers

NCT05723939
ZCICarnosine

Details and patient eligibility

About

Carnosine is a dipeptide synthesized in the body from β-alanine and L-histidine. It was originally discovered in skeletal muscle where it is present in larger amounts than in other tissues, but it is also found in high concentrations in the brain, heart, and gastrointestinal tissues of humans. Although its physiological role has not been completely understood yet, carnosine is a non-enzymatic free-radical scavenger and a natural antioxidant and has anti-inflammatory and neuroprotective properties.

The hypothesis of this research is that the consumption of carnosine supplements in the form of capsules, as well as chicken meat enriched with carnosine (functional food) has a beneficial effect on vascular reactivity measured in different vascular basins, and the lipid profile with a positive effect on the reduction of oxidative stress and inflammatory response in healthy sedentary people. subjects and active athletes measured in different vascular basins.

The main goal of this study is to investigate the influence of carnosine supplement consumption (in the form of capsules and functional food) on vascular and endothelial function in a population of healthy young subjects and active athletes.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • young healthy sedentary individuals - did not perform regular physical activities for at least 12 months before conducting the study
  • young healthy active athletes - have a minimum of 5 training sessions per week (mainly endurance training) for at least 12 months prior to conducting the study

Exclusion criteria

  • smoking
  • hypertension
  • coronary disease
  • diabetes
  • hyperlipidemia
  • kidney damage
  • cerebrovascular and peripheral artery diseases
  • and any other disease that could have an impact on vascular and endothelial function

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups, including a placebo group

Carnosine
Experimental group
Description:
Intake of carnosine supplement in form of capsules or functionally enriched chicken meet for three weeks
Treatment:
Dietary Supplement: Carnosine supplementation
Control
Placebo Comparator group
Description:
Intake of placebo capsules or regular chicken meet for three weeks
Treatment:
Dietary Supplement: Controls

Trial contacts and locations

1

Loading...

Central trial contact

Ines Drenjančević, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems